Influence on erythropoietin levels of treatment with cisplatinum-endoxan
- Cite this article as:
- Lechner, W., Artner-Dworzak, E., Sölder, E. et al. Arch Gynecol Obstet (1992) 252: 49. doi:10.1007/BF02389607
- 21 Downloads
Erythropoietin levels have been determined in 24 patients with different gynecologic malignancies, who were treated with cisplatinum and endoxan. A statistically highly significant decrease was demonstrated 2 h after starting treatment with a further significant decrease at 6 h. After 12 h the erythropoietin concentrations returned to values similar to those before treatment started.